Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-25 Option Award | 2023-02-28 4:08 pm | N/A 2032-02-25 | REVELATION BIOSCIENCES INC. | REVB | Rolke James Chief Executive Officer | 2,542 | $0 | 0 (Direct) | View |
Ownership | 2022-01-20 6:03 pm | N/A N/A | REVELATION BIOSCIENCES INC. | REVB | Rolke James Chief Executive Officer | 0 | $0 | 757,064 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A 2030-05-29 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 205 | $0 | 81,976 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 205 | $4.01 | 81,976 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A 2030-05-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $0 | 81,706 (Direct) | View |
| 2020-05-15 Option Award | 2020-05-19 4:05 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 140 | $5.86 | 81,706 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A 2030-04-30 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $0 | 81,559 (Direct) | View |
| 2020-04-30 Option Award | 2020-05-04 4:09 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 133 | $6.17 | 81,559 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A 2030-04-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $0 | 81,439 (Direct) | View |
| 2020-04-15 Option Award | 2020-04-17 4:02 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 146 | $5.61 | 81,439 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A 2030-03-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $0 | 81,376 (Direct) | View |
| 2020-03-31 Option Award | 2020-04-02 6:08 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 229 | $3.57 | 81,376 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A 2030-03-13 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $0 | 81,159 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-16 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 241 | $3.4 | 81,159 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A 2030-02-28 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $0 | 80,819 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 4:14 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 142 | $5.78 | 80,819 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:47 pm | N/A 2030-02-14 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 115 | $0 | 80,650 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:47 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 115 | $7.14 | 80,650 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A 2030-01-31 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 141 | $0 | 80,561 (Direct) | View |
| 2020-01-31 Option Award | 2020-02-04 4:01 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 141 | $5.82 | 80,561 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:13 pm | N/A 2030-01-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 692 | $0 | 80,971 (Direct) | View |
| 2020-01-15 Option Award | 2020-01-17 4:13 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 692 | $6.7 | 80,971 (Direct) | View |
| 2020-01-09 Option Award | 2020-01-13 4:19 pm | N/A 2030-01-09 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 30,000 | $0 | 30,000 (Direct) | View |
| 2019-11-15 Option Award | 2019-11-19 4:12 pm | N/A 2029-11-15 | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 118 | $0 | 79,705 (Direct) | View |
| 2019-11-15 Option Award | 2019-11-19 4:12 pm | N/A N/A | LA JOLLA PHARMACEUTICAL CO | LJPC | Rolke James Chief Scientific Officer | 118 | $5.12 | 79,705 (Direct) | View |